Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2019 – Children’s Cancer Therapy Development Institute